The Latest Breaking News on Pharma

If they do, the political fallout will be defined by industry group brawling.

If even Unilever, of all companies, is allowing its staff a 4 day work week then we know that shit works.

Editor's note: This story has been corrected to reflect that the FDA deferred action on Amicus Therapeutics' Biologics License Application. 

Timber Pharmaceuticals (TMBR) recently received an NYSE warning for not meeting the minimum trading price requirement for quite some time. The stock has lost 84% year-to-date. Given the company’s weak fundamentals, the stock could be a poor choice for investors enticed by its negligible price. Let’s discuss….

Consumer goods giant Unilever is expanding its four-day work week trial to Australia after impressive results in New Zealand.

Rachel Carson, a scientist and writer from rural Pennsylvania, published Silent Spring 60 years ago. Many credit this book, which meticulously documented the damage that DDT pesticides were inflicting on wildlife, farm animals and people as early as the 1950s, with launching the modern environmental movement.

Harmony crushed third-quarter forecasts and unveiled promising results for its narcolepsy drug — leading the biotech stock to surge Tuesday.

By Kevin Nicholson, COO of Delic and CEO of Ketamine Wellness Centers 

15 Global Psychedelics Executives To Keep An Eye On In 2022